Zribi, A., Al Riyami, K., Al Zahibi, H. S., & Burney, I. A. (2023). Managing the Adverse Events Associated with the Combination Pembrolizumab and Lenvatinib Therapy in Endometrial Cancer. Sultan Qaboos University Medical Journal, 1(1). https://doi.org/10.18295/squmj.9.2023.057